ArticleMolecular cancer therapeutics2023

The Bispecific Tumor Antigen-Conditional 4-1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies.

Michelle H Nelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.